News AI in drug discovery & development: News watch, October 2026 Recent news in biopharma AI include a $1.5bn partnership between AstraZeneca and insitro, plus news from Iambic, DaltonTx, NVIDIA, and Chai Discovery.
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
News Iambic files IPO after signing up AbbVie as new partner In the space of a day, Iambic has filed an IPO, released the latest version of its AI platform, and signed a multi-year alliance with AbbVie.
News Takeda signs $1.7bn AI alliance with Iambic Iambic bags another pharma partner, Takeda, which plans to use its AI platform to find drugs for cancer, gastrointestinal, and inflammatory disorders.
News Digital health hit hard by VC slump in 2023, says report There’s little doubt that financing for digital health companies remains in the doldrums.
News UK modernises gene therapy definition in regulatory revamp The UK is planning changes to the definition of gene therapies and other genetic medicines, moving to a mechanism-based approach aligned with the EU.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.